Why digital innovation matters more than ever
Life sciences is entering a pivotal period where digital innovation, data‑driven decision‑making and patient‑centred technologies are no longer optional - they are essential for sustainable success.
Organisations face increasing pressure to modernise, managing AI adoption, rising data complexity and tougher regulatory expectations at a pace never seen before.
This industry report features industry-led insights into the forces accelerating digital change in Life Sciences and the challenges leaders must respond to.
Take a look inside the report:
Regulatory and Compliance Challenges
Why regulation is becoming a strategic lever, and how leaders are using digital tools to manage complexity, build trust and enable innovation at pace.
Patient‑centred Technology
Exploring the shift towards outcome‑driven, patient‑first technologies and what it takes to design digital solutions that deliver real‑world impact.
AI and Data
A practical look at how data and AI is being applied today and outlining where value is actually being realised.
The Digital Transformation of Life Sciences
How organisations are moving beyond isolated initiatives to embed digital capability into core operating models.
The Road Ahead
Key themes shaping the future of Life Sciences, and the priorities leaders should focus on as digital maturity becomes a competitive differentiator.
Tarn Brown
Life Sciences Industry Lead at Columbus Global
Shaping value‑led digital transformation for life sciences organisations, designing compliant, phased roadmaps that align people, capability, and data integrity with measurable outcomes.
Massimo Crudeli
Director of Client Solutions at STAEDEAN
Trusted advisor in life sciences ERP and supply chain transformation, specialising in compliant, global system implementations across pharma and medical devices.
Chris Reid
Head of Digital Quality CoE at ProductLife Group
Global authority on digital quality and IT compliance, supporting life sciences organisations to adopt innovative technologies while maintaining GxP and data integrity.
Magnus Oxenwaldt
VP Group AI at Columbus Global
Driving AI strategy at Columbus Global and accelerating time-to-value for clients through AI-enhanced solutions.
Divya Vijay Pratheek
Vice President of Product and Marketing at Ribbon Bio
Biotechnology product leader shaping the future of synthetic DNA manufacturing, combining deep life sciences expertise with a focus on scalable, high‑precision production platforms.
Daniel Garner
Director of IT at Dental Directory Group
Leading digital and operational modernisation across one of the UK’s largest healthcare distribution networks, aligning technology, security, and supply chain systems to support regulated growth.
Gareth Willis
CEO and Co-founder of Exosla Therapeutics
Leading Exosla Therapeutics in developing scalable extracellular‑vesicle‑based immunotherapies, bridging translational science and next‑generation biologics manufacturing.
Stephanie Schorge
Head of Research Department at UCL
Advancing translational neuroscience research at UCL, driving academic–industry collaboration to advance neurological therapies from discovery to clinical impact.
Professor Alejandro Frangi
Bicentenary Turing Chair in Computation Sciences at The University of Manchester
World‑leading authority in computational medicine, advancing AI‑driven in‑silico trials and digital twins to transform how medical products are developed and regulated.
Oliver Johnson
Editor at MedTech Insights
MedTech journalist and editor covering innovation across medical devices, manufacturing, and the commercial forces shaping the global MedTech sector.
Steve Rozow
Co-Founder at Mach Medical
Medical device manufacturing pioneer focused on reinventing the orthopedic supply chain through high‑velocity, patient‑specific production models.
Whitepaper
Digital compliance for MedTech: Managaing regulatory complexity
Explore our latest MedTech whitepaper, providing a practical deep-dive into the regulatory and compliance challenges shaping the industry and how digitally enabled approaches are helping organisations respond.
